Aurobindo, Hetero, and Vivimed Class Action Settlements in North Dakota

All Aurobindo, Hetero, and Vivimed class action lawsuits and settlements available to North Dakota residents.

North Dakota residents have 1 active class action settlements involving Aurobindo, Hetero, and Vivimed that they can file claims for right now. Open settlements include $15.2M Valsartan, Losartan and Irbesartan class action settlement.

Class Action Buddy automatically files Aurobindo, Hetero, and Vivimed claims for North Dakota residents in under 60 seconds — no paperwork, no mailing, no proof of purchasey/proof-of-purchase/" style="color:#5D82F2;text-decoration:none;font-weight:500;">proof of purchase needed for most settlements.

About Aurobindo, Hetero, and Vivimed Class Actions in North Dakota

North Dakota residents affected by the Aurobindo, Hetero, and Vivimed pharmaceutical settlements have specific protections under state law. The North Dakota Consumer Fraud Act provides additional remedies for residents who purchased contaminated medications, allowing for potential treble damages in cases of willful violations. These three generic drug manufacturers supplied valsartan, losartan, and irbesartan medications containing NDMA and NDEA carcinogens to pharmacies throughout North Dakota, including major chains like Sanford Health pharmacies and local independent pharmacies. North Dakota's relatively small population means fewer claimants per settlement, potentially resulting in larger individual payouts for eligible residents. The state follows a six-year statute of limitations for consumer protection claims, which is longer than many neighboring states. North Dakota residents must typically provide proof of purchase through pharmacy records or insurance claims when filing for these pharmaceutical settlements. The state's Consumer Protection Division actively monitors these cases and has coordinated with federal agencies regarding the NDMA contamination issues affecting blood pressure medications distributed statewide.

How does North Dakota's Consumer Fraud Act affect my Aurobindo, Hetero, and Vivimed settlement claim?

North Dakota's Consumer Fraud Act provides additional protections beyond federal class action remedies, potentially allowing for treble damages if the contaminated medication sales constituted willful consumer fraud. This means North Dakota residents may have stronger legal grounds for claims compared to residents in other states.

Can North Dakota residents participate in the $15.2M valsartan settlement involving these manufacturers?

Yes, North Dakota residents who purchased valsartan, losartan, or irbesartan medications manufactured by Aurobindo, Hetero, or Vivimed are eligible for the settlement. You'll need pharmacy records or insurance documentation showing purchases of these specific generic medications between the relevant time periods.

What makes filing these claims different for North Dakota residents compared to other states?

North Dakota has a longer six-year statute of limitations for consumer protection claims and fewer total claimants, which may result in larger individual settlement amounts. The state's Consumer Protection Division also actively tracks these pharmaceutical cases and can provide additional resources for residents filing claims.

Tips for North Dakota Residents Filing Aurobindo, Hetero, and Vivimed Claims

North Dakota residents filing Aurobindo, Hetero, and Vivimed claims should gather all pharmacy records and insurance statements showing purchases of affected blood pressure medications. Contact your pharmacist to identify the specific manufacturer of your valsartan, losartan, or irbesartan prescriptions, as many pharmacies switched suppliers during the recall period. File claims promptly despite North Dakota's longer statute of limitations, as settlement deadlines are typically much shorter. Consider consulting with North Dakota attorneys experienced in pharmaceutical litigation, as the state's Consumer Fraud Act may provide additional remedies beyond class action settlements. Keep detailed medical records if you experienced health issues potentially linked to NDMA exposure from contaminated medications.

More North Dakota Resources